ICON, the international contract research organisation (CRO) based in Dublin, Ireland, has launched an enhanced version of ICOPhone, its technology platform for the delivery of Interactive Voice Response (IVR) and Interactive Web Response (IWR) services.

The updated ICOPhone comes with a reconfigurable electronic Patient Reported Outcomes (ePRO) module that can normally be implemented within four weeks, enabling pharmaceutical clients to expedite trial start-up and begin capturing patient data more quickly, ICON notes. According to Kris Gustafson, senior vice-president of the CRO’s Interactive Technologies group, the improved platform has the potential to reduce typical implementation times by more than 50%.

With the ICOPhone ePRO module, patient data may be collected at clinical trial sites or while patients are away from the site. The system offers real-time access to more accurate and reliable data, as well as faster validation of those data, ICON says.

The CRO recently entered into a technology partnership agreement with PHT, a US-based company that supplies hand-held electronic devices for use in clinical trials. The relationship was predicated on increasing demand for integrated technologies to capture Patient Reported Outcomes data during clinical development.